clinicaltrials

25-40% of clinical trial costs come from an excessive quality-check process that the FDA itself has recommended against for over a decade. Great piece from a former FDA official on why the whole system is stuck in a "too big to fail" loop. https://t.co/yX4gNVy04k https://t.co/sjbdVhioMF

Genuine question. How to be statistically & clinically significant on this interim OS data with longer follow up? https://t.co/kLXIRS6hQG

Had a conversation with someone outside of healthcare recently who was shocked by how long it takes to run clinical trials in the U.S (not to mention expensive). I tried to explain—it’s not just the science. It’s the infrastructure. Every site needs dozens of personnel, many of whom are required by regulatory frameworks... See more